These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 36688014)

  • 1. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
    Wang CR; Tsai HW
    World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets.
    Crispino F; Grova M; Bruno EM; Monachino N; Rizzo G; Casà A; Renna S; Macaluso FS; Orlando A
    Drugs; 2022 Jul; 82(11):1151-1163. PubMed ID: 35900700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
    Subramaniam K; Tymms K; Shadbolt B; Pavli P
    Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current issues in pediatric inflammatory bowel disease-associated arthropathies.
    Cardile S; Romano C
    World J Gastroenterol; 2014 Jan; 20(1):45-52. PubMed ID: 24415857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
    Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
    World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.
    Stolwijk C; Pierik M; Landewé R; Masclee A; van Tubergen A
    Can J Gastroenterol; 2013 Apr; 27(4):199-205. PubMed ID: 23616957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
    Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
    Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
    J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal lesions associated with spondyloarthropathies.
    Orlando A; Renna S; Perricone G; Cottone M
    World J Gastroenterol; 2009 May; 15(20):2443-8. PubMed ID: 19468992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease.
    Dubash S; Marianayagam T; Tinazzi I; Al-Araimi T; Pagnoux C; Weizman AV; Richette P; Tran Minh ML; Allez M; Singh A; Ciccia F; Hamlin J; Tan AL; Marzo-Ortega H; McGonagle D
    Rheumatology (Oxford); 2019 Jun; 58(6):963-968. PubMed ID: 30204909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.
    Beslek A; Onen F; Birlik M; Akarsu M; Akar S; Sari I; Gurler O; Akpinar H; Manisali M; Akkoc N
    Rheumatol Int; 2009 Jun; 29(8):955-7. PubMed ID: 19082597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The joint-gut axis in inflammatory bowel diseases.
    Brakenhoff LK; van der Heijde DM; Hommes DW; Huizinga TW; Fidder HH
    J Crohns Colitis; 2010 Sep; 4(3):257-68. PubMed ID: 21122514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
    Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
    Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatic manifestations in inflammatory bowel disease.
    Atzeni F; Defendenti C; Ditto MC; Batticciotto A; Ventura D; Antivalle M; Ardizzone S; Sarzi-Puttini P
    Autoimmun Rev; 2014 Jan; 13(1):20-3. PubMed ID: 23774109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on juvenile spondyloarthritis.
    Ramanathan A; Srinivasalu H; Colbert RA
    Rheum Dis Clin North Am; 2013 Nov; 39(4):767-88. PubMed ID: 24182854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases.
    Felice C; Pugliese D; Papparella LG; Pizzolante F; Onori E; Gasbarrini A; Rapaccini GL; Guidi L; Armuzzi A
    Expert Rev Clin Immunol; 2018 Sep; 14(9):751-759. PubMed ID: 30118354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].
    Protzer U; Duchmann R; Höhler T; Hitzler W; Ewe K; Wanitschke R; Meyer zum Büschenfelde KH; Märker-Hermann E
    Med Klin (Munich); 1996 Jun; 91(6):330-5. PubMed ID: 8767304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.